Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hackl

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Nature Communications|September 23, 2018
Towards synthetic cells using peptide-based reaction compartmentsKilian Vogele, Thomas Frank, Lukas Gasser, et al.
Chemical Communications (Cambridge, England)|August 16, 2018
Design and synthesis of tailored human caseinolytic protease P inhibitorsThomas F Gronauer, Melanie M Mandl, Markus Lakemeyer, et al.
Der Unfallchirurg|June 18, 2002
[Computer-assisted drilling of the lower extremity. Technique and indications]R E Rosenberger, R J Bale, C Fink, et al.
Yearbook of Medical Informatics|May 9, 2017
Evaluation Considerations for Secondary Uses of Clinical Data: Principles for an Evidence-based Approach to Policy and Implementation of Secondary AnalysisP J Scott, M Rigby, E Ammenwerth, et al.
Journal of the American Chemical Society|June 18, 2015
Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for DeoligomerizationMathias W Hackl, Markus Lakemeyer, Maria Dahmen, et al.
Paediatric Anaesthesia|January 1, 1996
A comparison of sevoflurance to halothane in paediatric surgical patients: results of a multicentre international studyB Kataria, R Epstein, A Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumorsB Markman, J Tabernero, I Krop, et al.
European Journal of Neurology|October 12, 2018
Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhageB Ianosi, M Gaasch, V Rass, et al.
Angewandte Chemie (International Ed. in English)|November 14, 2015
Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX AssociationAxel Pahl, Markus Lakemeyer, Marie-Theres Vielberg, et al.
Scientific Reports|May 28, 2021
Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancersMartina Meßner, Melanie M Mandl, Mathias W Hackl, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Nature Communications|September 23, 2018
Towards synthetic cells using peptide-based reaction compartmentsKilian Vogele, Thomas Frank, Lukas Gasser, et al.
Chemical Communications (Cambridge, England)|August 16, 2018
Design and synthesis of tailored human caseinolytic protease P inhibitorsThomas F Gronauer, Melanie M Mandl, Markus Lakemeyer, et al.
Der Unfallchirurg|June 18, 2002
[Computer-assisted drilling of the lower extremity. Technique and indications]R E Rosenberger, R J Bale, C Fink, et al.
Yearbook of Medical Informatics|May 9, 2017
Evaluation Considerations for Secondary Uses of Clinical Data: Principles for an Evidence-based Approach to Policy and Implementation of Secondary AnalysisP J Scott, M Rigby, E Ammenwerth, et al.
Journal of the American Chemical Society|June 18, 2015
Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for DeoligomerizationMathias W Hackl, Markus Lakemeyer, Maria Dahmen, et al.
Paediatric Anaesthesia|January 1, 1996
A comparison of sevoflurance to halothane in paediatric surgical patients: results of a multicentre international studyB Kataria, R Epstein, A Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumorsB Markman, J Tabernero, I Krop, et al.
European Journal of Neurology|October 12, 2018
Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhageB Ianosi, M Gaasch, V Rass, et al.
Angewandte Chemie (International Ed. in English)|November 14, 2015
Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX AssociationAxel Pahl, Markus Lakemeyer, Marie-Theres Vielberg, et al.
Scientific Reports|May 28, 2021
Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancersMartina Meßner, Melanie M Mandl, Mathias W Hackl, et al.
Pageof 10